Three genes, CCM1, CCM2, and CCM3, interact genetically and biochemically and are mutated in cerebral cavernous malformations (CCM). A recently described member of this CCM family of proteins, CCM2-like (CCM2L), has high homology to CCM2. Here we show that its relative expression in different tissues differs from that of CCM2 and, unlike CCM2, the expression of CCM2L in endothelial cells is regulated by density, flow, and statins. In vitro, both CCM2L and CCM2 bind MEKK3 in a complex with CCM1. Both CCM2L and CCM2 interfere with MEKK3 activation and its ability to phosphorylate MEK5, a downstream target. The in vivo relevance of this regulation was investigated in zebrafish. A knockdown of ccm2l and ccm2 in zebrafish leads to a more severe "big heart" and circulation defects compared with loss of function of ccm2 alone, and also leads to substantial body axis abnormalities. Silencing of mekk3 rescues the big heart and body axis phenotype, suggesting cross-talk between the CCM proteins and MEKK3 in vivo. In endothelial cells, CCM2 deletion leads to activation of ERK5 and a transcriptional program that are downstream of MEKK3. These findings suggest that CCM2L and CCM2 cooperate to regulate the activity of MEKK3.
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cerebral cavernous malformation | signaling | MAP kinase | expression | endothelium C erebral cavernous malformations (CCMs) are characterized by endothelial cell channels in low-blood flow venous capillaries with poor coverage of pericytes and smooth cells and poorly developed tight and adherens junctions, resulting in increased permeability, hemorrhage, and subsequent neurologic deficits. Germline loss-of-function mutations in any one of three CCM genes-CCM1 (Krit1), CCM2 (OSM), or CCM3 (PDCD10)-cause the familial and sporadic forms of CCMs. The proteins encoded by these genes interact in a cytosolic complex. Critical insights into their in vivo functions have been obtained from genetic manipulation in fish and mice.
In zebrafish, null mutations in either ccm1 (santa, san) or ccm2 (valentine, vtn) result in an enlarged heart ("big heart") and dilation of the subintestinal vessels and posterior cardinal vein, and morpholino (MO) studies indicate that ccm1 and ccm2 are in the same pathway during zebrafish cardiovascular development (1, 2) . The contribution of ccm3 or its downstream effectors in the ccm1/2 pathway in zebrafish is less clear (3, 4) . CCM proteins have been shown to regulate the signal strength of several pathways acting both as down-regulators and as activators. Reduced expression of CCM1, CCM2, or CCM3 increases RhoA activation (5). CCM2 and CCM3 siRNAs increase phosphorylation of AKT and the MAP kinases p38 and ERK1/2 (6). CCM1 promotes NOTCH activation (7) and deficiency in CCM proteins leads to endothelial-mesenchymal transition (EMT) by up-regulating TGF-β/BMP signaling (8) . ccm1 and ccm2 deletion in zebrafish leads to the up-regulation of β1-integrin signaling and klf2 expression that results in a proangiogenic program (9) . Ccm2-like (Ccm2l), a recently described paralog of Ccm2, was shown to have an antagonistic function to Ccm2 in cardiovascular development in mice and failed to rescue the phenotype in ccm2 null zebrafish (10) . However, in another study, ccm2l, like ccm2, was required for cardiovascular development in zebrafish, suggesting redundant functions for these two proteins (11) .
CCM2 has been shown to interact with the kinase MEKK3 (MAP3K3) (12) , and MEKK3 is known to activate several signaling pathways via the formation of specific signaling modules. The MEKK3-MEK5-ERK5 kinase module promotes cellular functions from EMTs to cell proliferation (13) and, in vivo, represents an important signaling axis in early cardiovascular development in mice (14, 15) .
Here we report differential regulation of CCM2 and CCM2L expression in endothelial cells, an interaction of these proteins with MEKK3′s N-terminal regulatory domain that interferes with its activation in vitro. Furthermore, genetic studies in zebrafish and cultured endothelial cells demonstrate MEKK3 dysregulation in the absence of these proteins.
Results and Discussion

CCM2L Tissue Expression and Regulation and Its Interaction with CCM1.
Several CCM2L isoforms exist (UniProt database). The canonical isoform 1 (long, 62 kD) and isoform 2 (short, 46 kD) retain a functional PTB domain (Fig. 1A) , implicated in CCM2 interaction with CCM1 and other signaling molecules (2) . Quantitative RT-PCR (qRT-PCR) primers that detect both isoforms 1 and 2 were used to evaluate their relative expression in vivo. mRNAs were detected in human umbilical vein endothelial cells (HUVEC)
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This article is a PNAS Direct Submission. and endothelial progenitor cells (Fig. 1B) . qRT-PCR primers that specifically detect only the long or short isoform indicated that the long isoform accounts for more than 90% of the mRNA for this gene product in all cells analyzed. The CCM2L isoforms were not detected in mononuclear cell fractions or neutrophils (Fig. 1B) , suggesting selective expression in endothelial lineages versus hematopoietic cells.
There is emerging evidence of an endothelial autonomous function for the CCM genes (5, 16, 17) . Here we analyzed CCM2L expression in endothelial cells under various biological settings. Several genes, such as claudin-5 (18) , are regulated by cell density. Confluent HUVEC monolayers replated at lower densities exhibited reduced CCM2L levels, suggesting that cell-cell contacts may be required to maintain optimal CCM2L levels ( Fig. 1C) , whereas CCM2 levels were largely unaffected, indicating distinct regulation of these two genes. Hemodynamic forces (shear stress) are strong modulators of the endothelial phenotype, and patterns of gene expression induced by flow can be recapitulated by statin treatment (19) . HUVEC monolayers subjected to shear stress or treated with statins showed up-regulation of CCM2L, but not CCM2, mRNA (Fig. 1D) . Thus, whereas CCM2L levels are dynamically regulated, CCM2 levels are not similarly responsive to cues that modulate the endothelial phenotype. All subsequent analyses of CCM2L were conducted in heterologous cells owing to the observed variability of expression in endothelial cells.
Mutations that impair CCM1-CCM2 interactions result in vascular malformations. The ability of CCM2L to interact with CCM1 was examined in transient transfection assays. As expected, CCM2 interacted with CCM1. Similarly, both CCM2L isoforms were found in complex with CCM1 ( Fig. 1E) , suggesting regulation of CCM2L by canonical CCM pathways.
CCM2 and CCM2L Interact with the MEKK3/MEK5 Complex and Regulate MEKK3 Activity. CCM2 has been identified as a scaffold protein for hypertonicity-induced MEKK3-p38 activation (12) . Here we show an interaction of CCM2 and CCM2L with MEKK3 ( Fig. 2A ) that did not involve the catalytic domain of the kinase, as they bound MEKK3 lacking this region and failed to interact with the kinase domain alone (Fig. 2B ). The binding of MEKK3 with CCM2L was consistently more robust than that with CCM2 ( Fig. 2A) . Similarly, transfected CCM2L interacted with endogenous MEKK3 in HUVEC as assessed in immunoprecipitation (IP) assays (Fig.  S1A ). The region of CCM2L mediating interaction with MEKK3 mapped to the C terminus (amino acids 357-571) of the canonical CCM2L, as isoform 2, which lacks these sequences, failed to interact with MEKK3 while retaining binding to CCM1 (Fig. 2C) . A recent study localized the region of interaction of CCM2 with MEKK3 to the harmonin homology domain of the CCM2L C terminus (20) . Based on these data, we mutated four hydrophobic amino acids in the predicted second α-helix of this domain in CCM2L, because in CCM2, the α1 and α2 helices form a hydrophobic cleft that accommodates the N-terminal α-helix of MEKK3 (20) . We found that this mutant did not bind MEKK3 (Fig. 2D ). CCM2L and CCM2 were also present in a ternary complex with CCM1 and MEKK3, because CCM1 immunoprecipitates contained MEKK3 only in the presence of CCM2L or CCM2 (Fig. 2E) . We next evaluated whether CCM2/CCM2L interacting with MEKK3 altered its function. Unlike other MAPKs, MEKK3 undergoes spontaneous activation in overexpression studies owing to its ability to autophosphorylate critical residues necessary for its kinase activity (21) . Endogenous MEKK3 is not constitutively active in the cell without the appropriate stimulus, indicating that self-activation is tightly regulated to avoid excessive kinase activation. Cotransfections of MEKK3 with CCM2L or CCM2 were performed, followed by MEKK3 pull-down and an in vitro kinase assay (Fig. 2F) . In this assay, on the addition of ATP, MEKK3 autophosphorylation results in reduced mobility of the kinase in SDS/PAGE gels (22) . Interestingly, the ability of CCM2L-bound MEKK3 to undergo autophosphorylation was substantially impaired; that is, the significant shift in mobility in the wild-type (WT) kinase did not occur in the presence of CCM2L and indeed was similar to that of an MEKK3 kinase inactive mutant (Fig. 2F) . Phosphorylation of Ser526 (p-Ser526) in the activation loop of MEKK3 plays a critical role in its activation (21) . MEKK3 complexed to CCM2L exhibited a significant reduction in p-Ser526, and the signal did not increase after the addition of ATP (Fig. 2F) . Like CMM2L, CCM2-bound MEKK3 showed diminished autophosphorylation (Fig. 2F) . Dimerization of MEKK2 is important for its activation by transphosphorylation (23) . We propose that the interaction with CCM2L or CCM2 prevents MEKK3 dimerization and thus its spontaneous activation. This may restrict MEKK3's activity and/or enable its activation in a stimulus-specific manner. This hypothesis predicts that the lack of this controlled activity will result in an unregulated population of MEKK3 under homeostatic conditions. MEK5, a kinase that interacts with MEKK3 and an important downstream effector, was also present in CCM2L immunoprecipitates, but only when MEKK3 was coexpressed (Fig. 2G) . We found that CCM2L in the MEKK3/MEK5 complex significantly attenuated MEKK3-mediated MEK5 phosphorylation (MEK5 p-Ser311/p-Thr315) in its activation loop (Fig. 2H) . The strong interaction of MEKK3 and CCM2L would predict a greater amount of inactive MEKK3 in the presence of CCM2L in total cell lysates. In agreement with this, cells containing MEKK3 and CCM2L showed a significant reduction in p-Ser526 compared with cells with MEKK3 alone (Fig. 2I) .
In summary, CCM2L and CCM2 interact with MEKK3, with CCM2L demonstrating greater binding, and both proteins prevent MEKK3 activity. Other MEKK3-interacting proteins also reportedly regulate kinase activation in in vitro assays. The interaction of TAK1 kinase with MEKK3 prevents its basal activation, and dissociation of the complex increases MEKK3 activity (22) . Moreover, the interaction of MEKK3 and MEKK2 with 14-3-3 proteins limits their ability to dimerize and autophosphorylate in the activation loop (24, 25) . The interaction of CCM2L with MEKK3 may prevent a feed-forward loop of MEKK3 activation by transphosphorylation, but might not in itself interfere with MEKK3's ability to phosphorylate all of its downstream targets. In this case, CCM2L may serve as a scaffold, as has been shown for CCM2. When CCM2L interacts with inactive MEKK3, it forms a stable complex (Fig. S1A ) that keeps MEKK3 inactive and prevents its activation by autophosphorylation (Fig. 2F) , whereas the interaction with active MEKK3 results in CCM2L phosphorylation, as demonstrated by its reduced mobility in SDS gels (Fig. S1A) . Whether phosphorylated CCM2L dissociates from this complex and allows dimerization and further kinase activation is an area of interest for future investigation. Thus, the regulation of MEKK3 likely is related to local amounts of CCM2L, whose dynamic expression may serve this purpose. The finding that the total pool of active MEKK3 in cell lysates is markedly reduced in the presence of CCM2L highlights the significance of this regulation.
Genetic Interaction of ccm2l with ccm2 and ccm1 in Zebrafish. We exploited the zebrafish model to address whether ccm2 and ccm2l are in the same pathway and regulate mekk3 function in vivo. Mutations in the zebrafish orthologs of CCM proteins result in distinct phenotypes that include a "big heart," characterized by an abnormally enlarged heart cavity, lack of circulation, and disruption of intersomitic vessels (26) . A MO designed to knock down ccm2l was injected into one-cell stage embryos of zebrafish expressing GFP in endothelial cells (flk-GFP) to visualize the vasculature. At 48 h postfertilization, ccm2l MOinjected fish displayed an enlarged atrium, ventricle, and pericardial cavity (big heart) ( Fig. 3A) , associated with mild reductions in heart rate [mean, 156 ± 8 bpm in controls (n = 6) vs. 140 ± 9 bpm in morphants (n = 11); P < 0.005] and cardiac output [44 ± 7 nL/min in controls (n = 6) vs. 32 ± 10 nL/min in morphants (n = 11); P < 0.05]. Vasculogenesis appeared grossly unaffected. This phenotype was dose-dependent; increasing amounts of ccm2l MO-1 resulted in more embryos with the heart enlargement/big heart phenotype ( Fig. 3B) , which is consistent with a previous report (11) . Injections of ccm2l MO into santa (san/ccm1) (Fig. 3C ) and valentine (vtn/ccm2) (Fig. 3D) heterozygous pair crosses demonstrated a strong genetic interaction between ccm2l and ccm1 or ccm2, which was more prominent with vtn/ccm2, as evidenced by a decrease in survival rate, a complete heart failure (HF) phenotype, and appearance of a markedly distorted body axis (Fig. 3  D and E) . Here 14% of vtn/ccm2 mutants sensitized with the ccm2l MO-1 (4 ng/μL) had a severe HF/axis phenotype, and 12% died. This was even more pronounced with the higher-dose injections (6 ng/μL), where 25% of vtn/ccm2 mutants showed HF/axis defects and 46% died. In similarly sensitized san/ccm1 mutants, 4% had the HF/axis defect and 0% died at 4 ng/μL ccm2l MO, and 41% had the HF/axis defect and 5% died at higher MO concentrations.
To further confirm the specificity of this phenotype and the genetic interaction with the CCM pathway, we injected a second MO (MO-2) against ccm2l in WT embryos and embryos generated by vtn/ccm2 intercrosses. We observed the same big heart phenotype in the injected WT embryos (Fig. S2 A and B) . Moreover, MO-2 injection in vtn/ccm2 embryos ( Fig. S2 C and  D) again resulted in a decrease in survival rates, and embryos with the HF/axis phenotype. These experiments were performed with lower doses of the MO-2, because the higher doses produced toxicity and poor survival.
Individual, differently classified zebrafish embryos from experiments were genotyped. The embryos with the axis defects correlated with embryos containing a mutant vtn allele in the presence of ccm2l MO, whereas no WT fish were detected in this group (Fig. S2E) . Control injections using a cardiac-specific MO (troponinT; tnnt2) in vtn/ccm2 mutants and the injection of ccm2l MO-1 into the silent heart mutants (sih/tnnt2) resulted in the expected big heart and silent phenotype, respectively, but with no additional tail axis defects (Fig. S2 F and G) . This indicates that the distorted axis/tail phenotype is specific to the ccm2l/ccm2 interaction, and that a defect in heart function is not responsible for the observed phenotype. These results suggest perturbed body axis patterning (27) , a phenotype not previously reported in ccm mutant lines (11, 26, 28) or in WT fish injected with ccm2l MO alone (11) .
Role for MEKK3 in a CCM Genetic Pathway in Zebrafish. Our biochemical results prompted us to investigate the role of MEKK3 in the body axis phenotype observed in the vtn/ccm2l morphants. Overexpression of MEKK3 in the vtn/ccm2l morphants by injection of in vitro translated MEKK3 mRNA resulted in more severe tail axis defects and cardiac failure (Fig. S2H) ; however, MOs directed to mekk3 efficiently rescued the tail axis defect (Fig. 3F) . Because rescue experiments usually require careful dosing of MOs, we chose to use the milder ccm2l MO 1 (MO-1) to rescue the CCM signaling loss-of-function-specific phenotypes. In this experiment, 33% of vtn/ccm2 embryos receiving only the ccm2l MO-1 showed a pronounced axis defect, compared with 19% receiving coinjection with the mekk3 MO (Fig. 3F) . Thus, mekk3 knockdown decreased the severity of the axial phenotypes, indicating that ccm2 and ccm2l modulation of mekk3 activity may be an important regulator of body axis patterning. Ccm2 and Ccm2l play antagonistic functions in cardiovascular development in mice (10) , whereas in zebrafish, ccm2l deficiency enhances ccm1 and ccm2 mutant phenotypes in heart development, as shown here by our experiments as well as in a previous study (11) .
Injection of the mekk3 MO into embryos generated by vtn/ccm2 intercrosses also reduced the prevalence of the big heart phenotype from 23% to 15% in mekk3 MO-injected embryos (Fig.  3G) , consistent with a recent report (29) . Similarly, the mekk3 MO reduced the big heart phenotype in WT fish injected with ccm2L MO (Fig. 3H) . The rescue of the body axis patterning phenotype in ccm2/ccm2l-deficient zebrafish and the big heart phenotype in single gene deficiency with mekk3 MOs demonstrates the importance of MEKK3 regulation by these two CCM-related proteins. Notably, ccm2l mRNA is located in the tail of embryos both in the cell mass ventral to the notochord and in the presumptive notochord (11) , an important structure in vertebral column development. ccm2 is also present in the ventral cell mass, whereas ccm1 mRNA is present in the notochord (26) . Moreover, MAPK pathways play key roles in notochord differentiation, with interference in this pathway leading to distortion in the tail axis (30) . Finally, using in vitro transcribed human CCM2L, we found that CCM2L isoform 1 significantly rescued the greater heart and tail axis defects observed in zebrafish mutants ( Fig. 3 I and J) . This suggests that the defects observed in ccm2l MO-injected zebrafish are specific and not due to offtarget effects.
CCM2 Deletion Leads to Activation of an MEKK3-Dependent Pathway.
In endothelial cells, activation of ERK5, a downstream effector of MEKK3, up-regulates Kruppel-like transcription factors (KLFs), which contribute to endothelial cell homeostasis. To examine whether CCM2 in endothelial cells regulates this pathway, we genetically deleted CCM2 using CRISPR/Cas9 lentiviral approaches in HUVEC. Knockdown of CCM2 using two independent guide RNAs led to ERK5 hyperactivation and up-regulation of KLF2 and KLF4. In agreement with the role of MEKK3 in this pathway, overexpression of this kinase in endothelial cells led to significant increases in KLF2 and KLF4 expression (Fig. 4) .
In conclusion, hyperactivation of MEKK3 in the absence of the CCM proteins CCM2 and/or CCM2L interferes with heart development and body axis patterning in zebrafish. This correlates in vitro with interference of MEKK3 hyperactivation by these CCM proteins. Although loss-of-function mutations in the newly identified CCM2L in human CCM lesions have not yet been reported, we predict that CCM2L regulation of MEKK3 can modify the severity of CCM disease. Because CCM2L expression is regulated by flow, low-flow conditions in CCM lesions may result in a reduction in CCM2L expression and subsequent exacerbation of MEKK3 activation, the tight regulation of which is required for formation of a normal vasculature. Genetic inactivation of members of the MEKK3 pathway results in embryonic lethality, characterized by defects in angiogenesis and early cardiovascular development (14, 15) . Our data in zebrafish are informative of the molecular mechanism of action of CCM2L; however, the link with the CCM disease in humans remains unclear, given that the phenotypes observed with a deficiency of CCM2L or other CCM proteins are not recapitulated in CCM patients. Nevertheless, features of the phenotypes reported in zebrafish, such as dilated vessels and defective tight junctions, are observed in CCM lesions.
Materials and Methods
All experiments were performed in Tuebingen AB zebrafish or Danio fish obtained from EkkWill Waterlife Resources. Zebrafish were bred and maintained at 28.5°C with 14-h light and 10-h dark exposure (day/night cycle), in accordance with the protocol approved by the Harvard Subcommittee for Animal Research. Detailed information on cDNA constructs and experimental procedures is provided in SI Materials and Methods.
